Melanoma antigen recognized by T-cells 1; MART-1
CAT No: ta-037
Synonyms/Alias:Melanoma antigen recognized by T-cells 1 (100-116);MART-1(100-116)
MART-1(100-116) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells 1 (MART-1), also known as Melan-A. As a defined epitope corresponding to residues 100 to 116 of the MART-1 protein, this peptide represents a critical sequence for immunological recognition in melanoma research. Its well-characterized structure and immunogenic properties make it a valuable reagent for studies focused on antigen processing, T cell activation, and tumor immunology. The peptide's sequence specificity and relevance to melanoma-associated antigens have established it as an important tool in the investigation of cellular immune responses and antigen presentation mechanisms.
Epitope mapping: Researchers utilize MART-1(100-116) to map antigenic determinants recognized by T cells, particularly within the context of melanoma immunology. By exposing immune cells to this defined peptide, investigators can identify and characterize the specific T cell receptors (TCRs) that interact with the MART-1 epitope, facilitating a deeper understanding of immune specificity and cross-reactivity. This mapping is vital for elucidating the molecular basis of immune recognition, which informs the design of immunological assays and experimental models.
T cell activation assays: The peptide is frequently employed in functional assays to stimulate and measure the activation of MART-1-specific T lymphocytes. In vitro systems using peripheral blood mononuclear cells (PBMCs) or isolated T cells enable quantitative assessment of cytokine production, proliferation, and cytotoxicity in response to antigen exposure. These assays are instrumental in evaluating the potency and specificity of T cell responses, supporting both basic research and the development of experimental immunotherapeutic strategies.
Antigen presentation studies: MART-1(100-116) serves as a model substrate for investigating the mechanisms of peptide processing and major histocompatibility complex (MHC) class II presentation. Researchers use the peptide to load antigen-presenting cells (APCs) and study the efficiency of peptide-MHC binding, stability, and presentation to CD4+ T cells. Insights gained from these studies contribute to the broader understanding of immune surveillance, antigen processing pathways, and the modulation of immune responses in the tumor microenvironment.
Immunomonitoring tools: In experimental settings, the peptide is incorporated into immunomonitoring protocols to detect and quantify antigen-specific T cells in blood or tissue samples. Techniques such as enzyme-linked immunospot (ELISPOT) assays, intracellular cytokine staining, and multimer staining utilize the peptide to track the frequency and functional status of MART-1-reactive T cells. These tools are essential for evaluating immune responses in preclinical models and for monitoring immune reactivity in translational research contexts.
Peptide-based assay development: The defined sequence and immunological relevance of MART-1(100-116) make it a preferred standard in the development and validation of peptide-based laboratory assays. Its use supports the optimization of protocols for peptide synthesis, purification, and functional testing. Additionally, the peptide provides a benchmark for assay sensitivity and specificity, ensuring reproducibility and reliability in experimental workflows focused on antigen-specific immune recognition.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.